Japanese and UK Biotech markets
(3rd Japan-UK Life Science Seminar)

Tuesday 16 June 2009
Co-organiser UK Trade & Investment
Co-organiser: Asia Pacific  Technology Network

This is the third in the “Japan/UK Life  Science Seminar Series” organised by the UK Trade & Investment and the Asia Pacific  Technology Network.  These quarterly seminars will provide an opportunity for UK  and Japanese companies in the pharmaceutical, biotechnology  and healthcare sectors to network, develop commercial ties and understand one another’s markets better.  

Chair

• Anil Vaidya, Sector Specialist-Biotechnology & Healthcare: Far East & Asia Pacific, UK Trade & Investment
• John T Kelly, Managing Director, Moffat Dickson Ltd

Speakers

• Dr Chizuko Koseki, Representative Director transB Ltd
  • "The Japanese Biotechnology Market"
• Tony Jones, Director of Biotechnology & Healthcare, London First/London Biotechnology Network
  • "The British Biotechnology Market"
• Dr Graham Scott, Senior Director, Clinical Pharmacology, Takeda Global R&D (Europe) Ltd
  • "Takeda's involvement with the UK" (working title)

Location: Department for Business Conference Centre, 1 Victoria  Street, London, SW1H 0ET
Nearest tube stations: St James Park or Westminster
Timing: Registration at 17.30: Session at 18.00: Networking and refreshments 19.45: finish 21.00
Pricing: £20 + VAT
To Register: Please send Name and Institutional Affiliation to biz@aptn.org

Chizuko Koseki
Dr. Koseki is a founder and director of transBLtd. She was also a board of director of Stelic Institute & Co., Tokyo-based privately owned Japanese biotech company until Nov 2008. Former to founding transB Ltd., she served as a vice president of Sosei Co. Ltd (4565, MOTHERS index) based in its UK operation for 8 years. She played a major role in establishing its unique business model, drug reprofiling platform (DRP®) . Prior to joining Sosei, she was working based in the UK as a consultant for various Japanese health care companies. Formerly, she held various positions as a researcher including a section chief in National Cardiovascular Research Institute (Japan), a visiting scientist in Colombia and Florida universities (USA), and an associate professor in Tokyo University (Japan). She holds Ph.D in pharmacology from Tokyo University.

Graham Scott
received a BSc in Pharmacy from Heriot-Watt University in 1980 and a PhD from the University of Strathclyde in 1985. He has worked in the pharmaceutical industry for 25 years for a various Pharmaceutical Companies in UK, USA and Switzerland. He joined Takeda in 2003 and currently serves as head of Clinical Pharmacology in Takeda Global Research & Development (Europe) based in central London.

Benefits

• A regular forum for UK and Japanese companies, providing in an environment facilitating the development of trade ties  
• Enhancing knowledge of the Japanese life sciences sector through a series of lively, up to date and  interesting presentations  
• Providing an opportunity for delegates to find out about  UK Government Support available to them to develop  international activity  

Who should attend?  

• Companies & entrepreneurs working within the pharmaceutical,  biotechnology, diagnostic and healthcare sector who are  interested in the Japanese life sciences sector.